Once daily dosing of netilmicin in neonatal and pediatric intensive care. 1994

B P Wagner, and J Pfenninger
Intensive Care Unit, University Children's Hospital, Inselspital, Bern, Switzerland.

OBJECTIVE To examine a once daily dosing regimen of netilmicin in critically ill neonates and children. METHODS Open, prospective study on 81 antibiotic courses in 77 critically ill neonates and children, hospitalized in a multidisciplinary pediatric/neonatal intensive care unit. For combined empiric therapy (aminoglycoside and beta-lactam), netilmicin was given intravenously over 5 min once every 24 h. The dose ranged from 3.5-6 mg/kg, mainly depending upon gestational and postnatal age. Peak levels were determined by immunoassay 30 min after the second dose and trough levels 1 h before the third and fifth dose or after adaptation of dosing. RESULTS All peak levels (n = 28) were clearly above 12 mumol/l (mean 22, range 13-41 mumol/l). Eighty-nine trough levels were within desired limits (< 4 mumol/l) and 11 (11%) above 4 mumol/l, mostly in conjunction with impaired renal function. CONCLUSIONS Optimal peak and trough levels of netilmicin can be achieved by once daily dosing, adapted to gestational/postnatal age and renal function.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009428 Netilmicin Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. Certomycin,Netillin,Netilmicin Sulfate,Netrocin,Netromicina,Netromycin,Netromycine,Nétromicine,Sch-20569,Sch 20569,Sch20569
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015931 Intensive Care, Neonatal Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting. Infant, Newborn, Intensive Care,Neonatal Intensive Care,Care, Neonatal Intensive
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical

Related Publications

B P Wagner, and J Pfenninger
January 1989, Clinical pharmacology and therapeutics,
B P Wagner, and J Pfenninger
February 1994, The Journal of antimicrobial chemotherapy,
B P Wagner, and J Pfenninger
January 1991, Wiener klinische Wochenschrift,
B P Wagner, and J Pfenninger
July 1998, Journal of pediatric surgery,
B P Wagner, and J Pfenninger
October 1988, Clinical pharmacology and therapeutics,
B P Wagner, and J Pfenninger
March 2010, Pharmacotherapy,
B P Wagner, and J Pfenninger
January 1990, The Journal of pediatrics,
B P Wagner, and J Pfenninger
July 1997, American family physician,
Copied contents to your clipboard!